Risk of Incident Non-Valvular Atrial Fibrillation after Dialysis-Requiring Acute Kidney Injury.
Chih-Chung ShiaoWei-Chih KanJian-Jhong WangYu-Feng LinLikwang ChenEric ChuehYa-Ting HuangWen-Po ChiangLi-Jung TsengChih-Hsien WangVin-Cent WuPublished in: Journal of clinical medicine (2018)
The influence of acute kidney injury (AKI) on subsequent incident atrial fibrillation (AF) has not yet been fully addressed. This retrospective nationwide cohort study was conducted using Taiwan's National Health Insurance Research Database from 1 January 2000 to 31 December 2010. A total of 41,463 patients without a previous AF, mitral valve disease, and hyperthyroidism who developed de novo dialysis-requiring AKI (AKI-D) during their index hospitalization were enrolled. After propensity score matching, "non-recovery group" (n = 2895), "AKI-recovery group" (n = 2895) and "non-AKI group" (control group, n = 5790) were categorized. Within a follow-up period of 6.52 ± 3.88 years (median, 6.87 years), we found that the adjusted risks for subsequent incident AF were increased in both AKI-recovery group (adjusted hazard ratio (aHR) = 1.30; 95% confidence intervals (CI), 1.07⁻1.58; p ≤ 0.01) and non-recovery group (aHR = 1.62; 95% CI, 1.36⁻1.94) compared to the non-AKI group. Furthermore, the development of AF carried elevated risks for major adverse cardiac events (aHR = 2.11; 95% CI, 1.83⁻2.43), ischemic stroke (aHR = 1.33; 95% CI, 1.19⁻1.49), and all stroke (aHR = 1.28; 95% CI, 1.15⁻1.43). (all p ≤ 0.001, except otherwise expressed) The authors concluded that AKI-D, even in those who withdrew from temporary dialysis, independently increases the subsequent risk of de novo AF.
Keyphrases
- acute kidney injury
- atrial fibrillation
- cardiac surgery
- left atrial
- end stage renal disease
- oral anticoagulants
- chronic kidney disease
- catheter ablation
- health insurance
- left atrial appendage
- direct oral anticoagulants
- mitral valve
- cardiovascular disease
- heart failure
- percutaneous coronary intervention
- healthcare
- quality improvement
- coronary artery disease
- ejection fraction
- risk assessment
- aortic valve
- adverse drug
- prognostic factors
- drug induced